Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan on Insulin Sensitivity in IGT
NCT00241072Phase 4Completed
- Sponsor
- Novartis
- Start
- Sep 2002
- Primary completion
- Jul 2005
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of valsartan in hypertension (HTN), impaired glucose tolerance (IGT), sponsored by Novartis. Started Sep 2002; status: completed.
02
Drugs
valsartan
03
Conditions
hypertension (HTN)impaired glucose tolerance (IGT)
Beyond the preview
Go deeper on NCT00241072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00241072.